Preview

Generoso Pharmaceutical & Chemical Inc.

Good Essays
Open Document
Open Document
808 Words
Grammar
Grammar
Plagiarism
Plagiarism
Writing
Writing
Score
Score
Generoso Pharmaceutical & Chemical Inc.
I. TIME CONTEXT

After five years of combining the Central Luzon region, in 1978, David established a company called Generoso Pharmaceuticals and Chemicals or GPC with Elizabeth a business associate, Rafael Buenaventura who was a salesman like David. The team set up shop at the Generoso residence in Tarlac. II. VIEWPOINT

The Generoso pharmaceuticals and Chemicals Inc. is an industry where selling the Medicine and Drugs etc. that owned by David with Elizabeth and Rafael. The problems of this industry are how to make compete to the other Pharmaceuticals industry, because those days there are many industries that sell the same product, How to make and generate their funds and how low will be stay in the Pharmaceuticals industry.

III. STATEMENT OF THE PROBLEMS

How will GPC stay in competition in pharmaceutical industry in the Philippines?
How will generate funds to continue with the project?
What will be the effect of the Generic Bill if they will continue to do the project? IV. OBJECTIVES

To know and determine the action of Generoso Pharmaceuticals and Chemicals in order to stay in the business.
To be able to generate funds for the implementation of the project.
To know the advantages and disadvantages of implementation of the Generic Bill in Generoso Pharmaceuticals and Chemical, Inc.

V. AREAS OF CONSIDERATION

* Competitors, Potential Substitutes and Potential Entrants
Potential competitors are not limited to the firms considering offering exactly the same or differential products or services; substitutes to the existing products and services are also potential threat. * Buyers and Suppliers
The competitive situation of the business is influenced by the nature of its transactions with its buyers and suppliers. * Governmental Intervention / Generic Acts of 1988
There are governmental institutions that as a component of the general environment, affect not only one industry. On the other hand, there are also

You May Also Find These Documents Helpful

  • Good Essays

    The five competitive forces among the industry are very important. However, rivalry among competing sellers, buyers and suppliers are the most important. Since the case discusses major wholesale clubs, the possibility of these being affected by potential new entrants is pretty low.…

    • 470 Words
    • 2 Pages
    Good Essays
  • Powerful Essays

    Suppliers The suppliers of the business would want that the products they have want to sell to the business is being bought at a profitable rate.…

    • 3737 Words
    • 15 Pages
    Powerful Essays
  • Powerful Essays

    Teva Pharmacuetical

    • 2882 Words
    • 12 Pages

    More than 100 years ago Teva Pharmaceuticals opened their doors as a wholesale drug distributor in Jerusalem. Today they have become the world’s leading producer of generic pharmaceuticals. Revenue has grown from $91 million in 1985 to $8.5 billion in 2006. This growth has not been easy and derives from key strategic decisions made along the way in order to amass these huge dollars amounts. Teva’s mission is to play a leading role in the transformation of the healthcare system through the development, manufacture and marketing of generic pharmaceuticals. Teva’s organizational structure is a symbol of their fundamental business strategy, highlighting their global strength and pharmaceutical diversity. This allows them to continue to expand their core generic business across all geographies and leverage their global reach and scientific strength to develop new innovative products and technologies. Teva has picked an industry in which there will always be a need, medicine. However, it is their approach to prescription medicine that will decide the future of Teva.…

    • 2882 Words
    • 12 Pages
    Powerful Essays
  • Good Essays

    “Don Ruiz, Chief Executive Officer: At age 37, Don became a young entrepreneur when he recruited four colleagues to make his brainchild -- Gene One -- a reality. As CEO and creative force behind Gene One, Don not only brought his extensive technology and industry knowledge to the company, but a significant part of the $2 million dollar start-up investment as well. Now, as a $400 million company, Gene One is positioned to realize growth targets that will make it an industry leader. Don is excited about the company 's…

    • 850 Words
    • 4 Pages
    Good Essays
  • Powerful Essays

    Here you will write about other businesses competing with your selected business for the same customers – you will identify how many competitors there are and who they are.…

    • 853 Words
    • 4 Pages
    Powerful Essays
  • Satisfactory Essays

    The Prescription drugs industry is one of my national economy important and special industry. It is closely related to people's health and life security, to protect and improve people's health has played a big role. Also, Industry's profit margin is very considerable. On the other hand, Prescription drug is a special kind of products, has a certain sensitivity, for the quality of the products and technology have very strict requirements. Because it is a direct effects on the human body, is closely related to people's health. The particularity of the industry is that ordinary consumers for the quality of the product and generally difficult to recognize and grasp the nature, generally trusted certification authority. Thus, From my perspective,…

    • 126 Words
    • 1 Page
    Satisfactory Essays
  • Better Essays

    Ventria’s financial goal is to make profit from producing in a big scale the GM rice they developed and selling it at an affordable price. The plant-made pharmaceutical concept was…

    • 1049 Words
    • 5 Pages
    Better Essays
  • Satisfactory Essays

    The company was founded in 1981 on the conservative belief that it should use revenues generated by selling reagents to generate cash flow and to create a track record that would allow it to fund further growth. Key factors that summarize the reasons for the rise of Genzyme from its marginal position in the high-risk biotechnology business to become a global player are as follows:…

    • 560 Words
    • 3 Pages
    Satisfactory Essays
  • Better Essays

    Genzyme Case Study

    • 894 Words
    • 4 Pages

    Henri Termeer started Genzyme Corporation with ten employees and then grew it to a corporation that now has four billion in sales per year. Genzyme is a biotechnology company that specializes in finding orphan drugs, which specifically cure enzyme deficiency conditions. To offer a brief explanation, an orphan drug is a pharmaceutical agent developed to cure a rare, orphan, disease. In order to find the cures for these rare diseases, technology using living biological systems and living organisms is used, which is known as biotechnology. In order for a biotechnology firm to succeed time is needed to give the firm the opportunity to find a successful product. According to Mr. Termeer, this requires that upon investing in a biotechnology firm you wait for results and the investment is long term.…

    • 894 Words
    • 4 Pages
    Better Essays
  • Better Essays

    This was an U.S. based company and it had opened its subsidiary by the name of CompCare where it has formulated the new drug so that it can sell that drug to all individuals and various pharmacies outlets on the basis of required prescription. Once FDA researched and they discovered that PharmaCare pharmacist are reformulating the drug AD23 to maximize its effects, CompCare will get protected by patenting the new drug under the FDA and U.S. patent and U.S. Federal Trademark laws. (“STATE REGULATION OF COMPOUNDING PHARMACIES”)…

    • 2774 Words
    • 12 Pages
    Better Essays
  • Powerful Essays

    Analysis of the Medicines Company case revealed several critical aspects that need to be addressed. The pharmaceutical industry can be very profitable, but is also very risky. As described in the case, bringing a new drug to market is a costly and lengthy process requiring an average of 10 years. Big Pharmaceutical companies struggle to keep upcoming drugs in their pipeline to provide revenue when existing drugs come off patent and are replaced by generic compounds. With 1 in 4000 compounds making it to market, there is significant risk of failure that can be reduced by having many compounds in development. Additionally, a drug company's reputation can easily be tarnished by safety issues with a compound, dramatically affecting their sales.…

    • 2114 Words
    • 7 Pages
    Powerful Essays
  • Good Essays

    Biogen Analysis

    • 7813 Words
    • 32 Pages

    Biogen is in a strong position within the biotechnology industry. It is one of just seventeen profitable biotech companies and has the fourth largest market capitalization. Biogen has attained this prestige by utilizing partnerships from the beginning of the company which has definitely paid off. By partnering with some of the larger pharmaceutical companies, Biogen has created many competitive advantages. The main competitive advantages have been access to capital and drug marketing. Lack of capital (running out of cash) is what bankrupts most young biotechnology firms.…

    • 7813 Words
    • 32 Pages
    Good Essays
  • Powerful Essays

    Eli Lilly

    • 2933 Words
    • 12 Pages

    This case outlines the difficulty faced by Eli Lilly, a pharmaceutical company’s decision as to whether they should develop a lead migraine compound. This decision is faced by the Project Manager Bianca Sharma and she has to make recommendations in the PTAC meeting. A number of things have to be considered like- time to market, diversity of leads, traditional or combinatorial chemistry etc. which is unique to the pharmaceutical industry. Other factors which might not be unique to this industry but still has to be considered in this analysis are- intellectual property (IP), funding for clinical trials, reliability of the product and process, alternatives to the product, firm’s short term and long term strategy, market conditions etc.…

    • 2933 Words
    • 12 Pages
    Powerful Essays
  • Good Essays

    Porter Airlines

    • 2655 Words
    • 11 Pages

    Availability of Substitutes - What is the likelihood that someone will switch to a competitive product or service? If the cost of switching is low, then this poses a serious threat. Here are a few factors that can affect the threat of substitutes:…

    • 2655 Words
    • 11 Pages
    Good Essays
  • Powerful Essays

    Genzyme

    • 3375 Words
    • 14 Pages

    "What's the case to shareholders, and how does your board of directors support this?" was the next question asked to Geraghty. He explained that historically, pharmaceutical companies have not had great relationships with governments in developing and emerging countries. Yet those are, of course, important markets for companies like Genzyme. "Governments are the decision makers. We want to develop their respect as partners, so that we can bring forward our commercial portfolio in the future." Genzyme's portfolio includes drugs for rare inherited disorders, renal disease, cancer, orthopedics, and…

    • 3375 Words
    • 14 Pages
    Powerful Essays